PITRM1 and Alzheimer disease: Because defects in mitophagy have been shown to contribute to AD [33], and ISRIB-treated cerebral organoids showed decreased mitochondrial clearance and the exacerbation of AD-like phenotypes, we investigated whether enhancing mitochondrial clearance ameliorates the AD-like phenotype in PITRM1-related mitochondrial neurodegeneration.